Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Ensuring psychedelic treatments and research do not leave anyone behind
    Published on 2023-08-21
    2 years ago
  • Epigenetic alterations identify a confluence of genetic vulnerabilities tied to opioid overdose
    Published on 2023-08-16
    2 years ago
  • Finding new and better treatments for psychiatric disorders
    Published on 2023-08-15
    2 years ago
  • A path to novel, effective treatments for schizophrenia
    Published on 2023-08-14
    2 years ago
  • Calcitonin receptor signal: a potential target for opioid use disorder?
    Published on 2023-08-14
    2 years ago
  • Unraveling the cell-type-specific molecular pathways of PTSD: integrating GWAS with brain genomic profiling and in vitro modeling
    Published on 2023-08-14
    2 years ago
  • Towards personalized medicine: subtyping using functional profiles
    Published on 2023-08-14
    2 years ago
« Previous 1 … 65 66 67 68 69 … 143 Next »
Journal of Psychopharmacology
  • Efficacy and tolerability of pharmacological interventions on metabolic disturbance induced by atypical antipsychotics in adults: A systematic review and network meta-analysis
    Published on 2021-07-27
    4 years ago
  • The dosing procedure that “makes the poison”: Comparing the effects of single versus cumulative alcohol administration methods on emotion recognition
    Published on 2021-07-27
    4 years ago
  • Association study of BDNF Val66Met gene polymorphism with bipolar disorder and lithium treatment response in Indian population
    Published on 2021-07-27
    4 years ago
  • Mice lacking melatonin MT2 receptors exhibit attentional deficits, anxiety and enhanced social interaction
    Published on 2021-07-24
    4 years ago
  • Transgenerational evidence of increases in dopamine D2 receptor sensitivity in rodents: Impact on sensorimotor gating, the behavioral response to nicotine and BDNF
    Published on 2021-07-22
    4 years ago
  • Effects on suicidal risk: Comparison of clozapine to other newer medicines indicated to treat schizophrenia or bipolar disorder
    Published on 2021-07-22
    4 years ago
  • Pharmacological treatment for Tourette syndrome in children and adults: What is the quality of the evidence? A systematic review
    Published on 2021-07-21
    4 years ago
« Previous 1 … 65 66 67 68 69 … 124 Next »
European Neuropsychopharmacology
  • Pharmacological characterization of 3,4-methylenedioxamphetamine (MDA) analogs and two amphetamine-based compounds: N,α-DEPEA and DPIA
    Published on 2022-04-02
    3 years ago
  • Is it time to change the term negative symptoms?
    Published on 2022-04-02
    3 years ago
  • Psychiatric disorders in Post-acute COVID-syndrome (PDPACS): Recommendations for health care professionals
    Published on 2022-03-27
    3 years ago
  • Corrigendum to “34th ECNP Congress – Lisbon 2021 Hybrid. P.0877 Lithium treatment influences blood transcriptome during manic but not depressive episode in bipolar patients” [European Neuropsychopharmacology 2021 53S1. S642]
    Published on 2022-03-23
    3 years ago
  • Psychotherapeutic interventions specifically developed for NSSI in adolescence: A systematic review
    Published on 2022-03-22
    3 years ago
  • Pediatric Bipolar Disorder – Misinformation with Unintended Negative Consequences for Children and Adolescents
    Published on 2022-03-21
    3 years ago
  • Early intervention comes late
    Published on 2022-03-20
    3 years ago
« Previous 1 … 65 66 67 68 69 … 145 Next »

   Pharma Pub